Patent · US Active

Drug-delivery stent formulations for restenosis and vulnerable plaque

US8017140B2 · kind B2 · utility

0Cited by

225References

10Claims

0Family size

Assignee

Advanced Cardiovascular Systems, Inc. · US

Inventors

Syed Faiyaz Ahmed Hossainy · Fremont, US
Gordon Stewart · San Francisco, US
Deborah Kilpatrick · Mountain View, US
Jeffrey T. Ellis · Mountain View, US
Gene Park · Oakland, US
Gina Zhang · Calabasas, US
Paul Consigny · San Jose, US
Yiwen Tang · San Jose, US

Key dates

Filing date	May 21, 2007
Grant date	Sep 13, 2011
Priority date	—
Expiry date	May 21, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/45
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Drug-delivery stents capable of providing release of two or more drugs such as everolimus and estradiol are provided. The stents can be used for treating a disease such as restenosis and vulnerable plaque.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.